Huber C - Search Results

1

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.

Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Jung D, et al. Among authors: huber c. Scand J Immunol. 1999 Sep;50(3):242-9. doi: 10.1046/j.1365-3083.1999.00588.x. Scand J Immunol. 1999. PMID: 10447932 Free article.

2

Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.

Seliger B, Höhne A, Jung D, Kallfelz M, Knuth A, Jaeger E, Bernhard H, Momburg F, Tampé R, Huber C. Seliger B, et al. Among authors: huber c. Exp Hematol. 1997 Jul;25(7):608-14. Exp Hematol. 1997. PMID: 9216736

3

Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.

Seliger B, Dunn T, Schwenzer A, Casper J, Huber C, Schmoll HJ. Seliger B, et al. Among authors: huber c. Scand J Immunol. 1997 Dec;46(6):625-32. doi: 10.1046/j.1365-3083.1997.d01-176.x. Scand J Immunol. 1997. PMID: 9420627 Free article.

4

Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.

Jung D, Jaeger E, Cayeux S, Blankenstein T, Hilmes C, Karbach J, Moebius U, Knuth A, Huber C, Seliger B. Jung D, et al. Among authors: huber c. Hum Gene Ther. 1998 Jan 1;9(1):53-62. doi: 10.1089/hum.1998.9.1-53. Hum Gene Ther. 1998. PMID: 9458242

5

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Neumann E, Engelsberg A, Decker J, Störkel S, Jaeger E, Huber C, Seliger B. Neumann E, et al. Among authors: huber c. Cancer Res. 1998 Sep 15;58(18):4090-5. Cancer Res. 1998. PMID: 9751617

6

IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.

Seliger B, Hammers S, Höhne A, Zeidler R, Knuth A, Gerharz CD, Huber C. Seliger B, et al. Among authors: huber c. Clin Cancer Res. 1997 Apr;3(4):573-8. Clin Cancer Res. 1997. PMID: 9815722

7

Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.

Kallfelz M, Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Kallfelz M, et al. Among authors: huber c. Int J Cancer. 1999 Mar 31;81(1):125-33. doi: 10.1002/(sici)1097-0215(19990331)81:1<125::aid-ijc21>3.0.co;2-2. Int J Cancer. 1999. PMID: 10077163

8

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.

Seliger B, Harders C, Lohmann S, Momburg F, Urlinger S, Tampé R, Huber C. Seliger B, et al. Among authors: huber c. Eur J Immunol. 1998 Jan;28(1):122-33. doi: 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F. Eur J Immunol. 1998. PMID: 9485192 Free article.

9

Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.

Seliger B, Höhne A, Knuth A, Bernhard H, Ehring B, Tampé R, Huber C. Seliger B, et al. Among authors: huber c. Clin Cancer Res. 1996 Aug;2(8):1427-33. Clin Cancer Res. 1996. PMID: 9816317

10

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.

Seliger B, Rongcun Y, Atkins D, Hammers S, Huber C, Störkel S, Kiessling R. Seliger B, et al. Among authors: huber c. Int J Cancer. 2000 Aug 1;87(3):349-59. Int J Cancer. 2000. PMID: 10897039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,860 results

Search Page

Filters